Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01500733. IPD Sharing: Not stated. Countries: 1. Publications: 17.
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies
ClinicalTrials.gov study NCT03932331. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
ClinicalTrials.gov study NCT03824483. IPD Sharing: YES. Countries: 1. Publications: 2.
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00759798. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small L
ClinicalTrials.gov study NCT04666038. IPD Sharing: Not stated. Countries: 24. Publications: 1.
Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00058240. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02340780. IPD Sharing: NO. Countries: 1. Publications: 1.
Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00513747. IPD Sharing: Not stated. Countries: 2. Publications: 1.
CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00290472. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia
Open the record for dataset details and reuse information.
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00276848. IPD Sharing: NO. Countries: 2. Publications: 7.
Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00024440. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00005580. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00810680. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01098188. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
ClinicalTrials.gov study NCT02559583. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00022971. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00262795. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02015208. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00645606. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.